EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effects of Remotely Delivered and Web-Based Interventions on Depression Severity During the COVID-19 Pandemic: 3-Arm Randomized Controlled Trial

Auswirkungen von per Fernzugriff und webbasiert durchgeführten Interventionen auf die Depressionsschwere während der COVID-19-Pandemie: 3-armige randomisierte kontrollierte Studie

Zev Schuman-Olivier, Liv Valö, Joseph A Rosansky, Gareth Parry, Alexandra Comeau, Fiona Kate Rice, Carl Fulwiler

JMIR Mental Health · 04.08.2026 · 13 · e88388-e88388

DOI: 10.2196/88388 ↗

Auf einen Blick

In einer 3-armigen RCT sanken die Depressionssymptome in allen Gruppen. Weder MBCT-R+CHA-MW noch iCBT+CHA-MW war CHA-MW allein überlegen.

Fragestellung

Verbessert MBCT-R oder iCBT zusätzlich zu CHA-MW die Depressionsschwere im Vergleich zu CHA-MW allein während der COVID-19-Pandemie?

Methode

3-armige randomisierte klinische Studie; 97 Teilnehmende; Remote-/Web-Interventionen; Auswertung per Intention-to-treat über 24 Wochen.

Ergebnisse

MBCT-R+CHA-MW: mittlere Differenz −14,1 (95 %-KI −21,0 bis −7,2); CHA-MW: −15,2 (95 %-KI −21,8 bis −8,6); iCBT+CHA-MW: −12,7 (95 %-KI −17,4 bis −8,1). Keine signifikanten Gruppenunterschiede.

Einschränkungen

Niedrige Abschlussraten: MBCT-R 30 %, iCBT 24 %.

Schlussfolgerung der Autor:innen

MBCT-R+CHA-MW, iCBT+CHA-MW und CHA-MW waren jeweils wirksam gegen Depression; keine Intervention war in der Intention-to-treat-Analyse überlegen. CHA-MW war während der Pandemie ebenso wirksam wie aufwendigere Interventionen.

Kernaussagen

  • Depressionssymptome nahmen in allen 3 Gruppen ab.
  • Keine Überlegenheit von MBCT-R oder iCBT gegenüber CHA-MW.
  • Geringe Abschlussraten könnten die Ergebnisse beeinflusst haben.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Mental Health, online erschienen am 04.08.2026. Verfasst von Zev Schuman-Olivier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Center for Mindfulness and Compassion, Cambridge Health Alliance, 350 Main Street, Suite 5126, Malden, MA, 02148, United St…. Hauptthemen laut MEDLINE: COVID-19, Depression, Internet-Based Intervention, Cognitive Behavioral Therapy. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCIH NIH HHS.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 pandemic highlighted a critical need for effective population mental health approaches to target the most prevalent disorders (eg, depression) during periods of elevated community distress. The effectiveness of remotely delivered and web-based interventions should be investigated to identify and innovate high-quality models for population mental health service delivery.

Objective

The primary objective investigated the effectiveness of adding Mindfulness-Based Cognitive Therapy for Resilience (MBCT-R)—a live, online, synchronous, remotely delivered, group-based intervention—to Cambridge Health Alliance MindWell (CHA-MW), a web-based population health screening and stratified support program, compared with CHA-MW alone, on depression symptom severity. The secondary objective evaluated adding internet Cognitive Behavioral Therapy (iCBT)—an asynchronous, web-based, individual, digital intervention—to CHA-MW, compared with CHA-MW alone.

Methods

Participants (N=97) were randomized in a 2:2:1 ratio to receive MBCT-R+CHA-MW (n=37), iCBT+CHA-MW (n=41), or CHA-MW alone (n=19) in a 3-arm randomized clinical trial, from May 2021 to September 2022 in an urban public safety net hospital outpatient setting. CHA-MW served as a low-intensity control condition. For the MBCT-R+CHA-MW arm, MBCT-R was an 8-session program mildly adapted from MBCT to address COVID-19–related risks for depression. For the iCBT+CHA-MW arm, iCBT was a 6-session curriculum added to CHA-MW. All study procedures, including regular mental health symptom screenings, were conducted remotely or via a web-based platform. The primary outcome was change in depression symptom severity during the 24-week study period using an intention-to-treat approach that used generalized linear mixed-effects models to evaluate the comparative effectiveness of MBCT-R+CHA-MW vs CHA-MW over time. A secondary analysis compared iCBT+CHA-MW vs CHA-MW on depression severity. Completer analyses were conducted (per-protocol 6+ sessions). The secondary outcome was mental health visit utilization frequency during the study period.

Results

Both MBCT-R+CHA-MW (mean difference −14.1, 95% CI −21.0 to −7.2) and CHA-MW (mean difference −15.2, 95% CI −21.8 to −8.6) had significant reductions in depression symptom severity, with no statistically significant between-group differences. iCBT+CHA-MW (mean difference −12.7, 95% CI −17.4 to −8.1) also reduced depression symptoms but without between-group differences when compared with CHA-MW. Intervention completion rates were low (MBCT-R: 30% and iCBT: 24%), and completers demonstrated significantly greater reductions in depression severity than noncompleters (mean difference −8.5, 95% CI −16.2 to −0.8). Overall mental health clinician visits by group had no statistically significant differences. CHA-MW had the largest increase in participants with new psychopharmacology treatment visits during the 24-week study (CHA-MW +21%, MBCT-R +10%, and iCBT −5%).

Conclusions

MBCT-R+CHA-MW, iCBT+CHA-MW, and CHA-MW were each effective in treating depression, without any intervention demonstrating superiority in intention-to-treat analyses. CHA-MW was as efficacious during the COVID-19 pandemic as more resource-intensive interventions that demanded greater time and effort from participants. Low completion rates for MBCT-R and iCBT during the COVID-19 pandemic may have contributed to these results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19DepressionInternet-Based InterventionCognitive Behavioral TherapyMindfulnessHumansFemaleAdultMaleMiddle AgedMental Health TeletherapySeverity of Illness IndexInternetTelemedicinePandemics

Stichwörter der Autor:innen

COVID-19 pandemicMindfulness-Based Cognitive Therapycognitive behavioral therapydepressiondigital healtheHealthmindfulnesspopulation mental healthrandomized controlled trialstratified caretelehealth

Autor:innen und Institutionen

  • Department of Psychiatry, Center for Mindfulness and Compassion, Cambridge Health Alliance, 350 Main Street, Suite 5126, Malden, MA, 02148, United States, 1 617-591-6056.
  • Department of Psychiatry, Harvard Medical School, Boston, MA, United States.

Förderung

  • NCCIH NIH HHS

Zitieren

APA

Schuman-Olivier, Z., Valö, L., Rosansky, J. A., Parry, G., Comeau, A., Rice, F. K., & Fulwiler, C. (2026). Effects of Remotely Delivered and Web-Based Interventions on Depression Severity During the COVID-19 Pandemic: 3-Arm Randomized Controlled Trial. JMIR Mental Health, 13, e88388-e88388. https://doi.org/10.2196/88388

Vancouver

Schuman-Olivier Z, Valö L, Rosansky JA, Parry G, Comeau A, Rice FK, et al. Effects of Remotely Delivered and Web-Based Interventions on Depression Severity During the COVID-19 Pandemic: 3-Arm Randomized Controlled Trial. JMIR Mental Health. 2026;13:e88388-e88388. doi:10.2196/88388

BibTeX
@article{SchumanOlivier2026,
  author = {Schuman-Olivier, Zev and Valö, Liv and Rosansky, Joseph A and Parry, Gareth and Comeau, Alexandra and Rice, Fiona Kate and Fulwiler, Carl},
  title = {Effects of Remotely Delivered and Web-Based Interventions on Depression Severity During the COVID-19 Pandemic: 3-Arm Randomized Controlled Trial},
  journal = {JMIR Mental Health},
  year = {2026},
  volume = {13},
  pages = {e88388--e88388},
  doi = {10.2196/88388}
}
Kostenlos starten →